Inventor · disambiguated record
Simon Stewart Jones
Also filed as: JONES SIMON S · JONES SIMON STEWART
10 granted patents·11 pending applications·47 citations·filing 2013–2023
86Inventor score
Top patents by PatentIndex Score
21 records- 0190US9278963B2Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Mar 8, 2016·17 cites·24 claims
- 0289US9663825B2Biomarkers to identify patients that will respond to treatment and treating such patientsYANG MIN·Filed 2013·Granted May 30, 2017·10 cites·5 claims
- 0386US9403779B2Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Aug 2, 2016·10 cites·4 claims
- 0485US11337975B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted May 24, 2022·2 cites·5 claims
- 0580US9833466B2Treatment of leukemia with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2015·Granted Dec 5, 2017·5 cites·10 claims
- 0676US10722512B2Combinations of histone deacetylase inhibitors and either HER2 inhibitors or PI3K inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Granted Jul 28, 2020·1 cites·6 claims
- 0774US2023364083A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0873US12053468B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Granted Aug 6, 2024·0 cites·14 claims
- 0972US9949972B2Combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2014·Granted Apr 24, 2018·2 cites·7 claims
- 1069US2023190744A1Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (pd-l1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1166US2020323849A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsACETYLON PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1264US2020405716A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1363US11497746B2Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (PD-L1) inhibitor and methods of use thereofACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Nov 15, 2022·0 cites·3 claims
- 1457US2015105358A1Combinations of histone deacetylase inhibitors and immunomodulatory drugsQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1556US2015176076A1Histone deacetylase 6 (hdac6) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1648US2014357512A1Histone deacetylase (hdac) biomarkers in multiple myelomaACETYLON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1743US2015105383A1HDAC Inhibitors, Alone Or In Combination With PI3K Inhibitors, For Treating Non-Hodgkin's LymphomaQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 1842US2016279128A1Pyrimidine hydroxy amide compounds as histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1940US2016339022A1Treatment of neuroblastoma with histone deacetylase inhibitorsACETYLON PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2038US2015105409A1Hdac inhibitors, alone or in combination with btk inhibitors, for treating nonhodgkin's lymphomaQUAYLE STEVEN NORMAN·Filed 2014·Application pending·0 cites
- 2136US11813261B2HDAC inhibitors, alone or in combination with BTK inhibitors, for treating chronic lymphocytic leukemiaACETYLON PHARMACEUTICALS INC·Filed 2017·Granted Nov 14, 2023·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Simon Stewart Jones files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →